Cargando…
Finding the Right Heavy Chains for Immunostimulatory Antibodies
For twelve years, the oncology field has been revolutionized by antibodies targeting immune checkpoints. They must be considered as a heterogenous family of immunostimulatory antibodies displaying very different mechanisms of action, not only depending on the target or on the cells expressing it, bu...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499592/ https://www.ncbi.nlm.nih.gov/pubmed/36142278 http://dx.doi.org/10.3390/ijms231810367 |